Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual-patient data from six randomized clinical trials

Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual-patient data from six randomized clinical trials Peter M. Fayers, Antonio Palumbo, Cyrille Hulin, Anders Waage, Pierre Wijermans, Meral Beksaç, Sara Bringhen, Jean-Yves Mary, Peter Gimsing, Fabian Termorshuizen, Rauf Haznedar, Tommaso Caravita, Philippe Moreau, Ingemar Turesson, Pellegrino Musto, Lotfi Benboubker, Martijn Schaafsma, Pieter Sonneveld, Thierry Facon on behalf of NMSG, GIMEMA, TMSG, HOVON, IFM, and European Myeloma Network. Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; Divisione di Ematologia dell'Università di Torino, A.O.U. S. Giovanni Battista, Torino, Italy; Hematology Department, University Hospital, Nancy, France; Department of Hematology, St. Olavs University Hospital, Trondheim, Norway; Department of Hematology, Haga Hospital, The Hague, The Netherlands; Department of Hematology, Ankara University, Ankara, Turkey; Divisione di Ematologia dell'Università di Torino, A.O.U. S. Giovanni Battista, Torino, Italy; INSERM U717, Université Paris 7, Hôpital Saint-Louis, Paris, France; Department of Hematology, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark; Erasmus Medical Center and University, Rotterdam, The Netherlands; Department of Hematology , Gazi University School of Medicine, Ankara, Turkey; Cattedra e Divisione di Ematologia, Università Tor Vergata, Ospedale S. Eugenio, Roma, Italy; Centre Hospitalier Universitaire, Nantes, France; Department of Hematology, Skane University Hospital, Malmö, Sweden; Department of Onco-Hematology, IRCCS "Centro di Riferimento Oncologico della Basilicata" Rionero in Vulture (Pz), Italy; Oncohématologie CHRU, Hôpital Bretonneau, Tours, France; Medical Spectrum Twente, Enschede, The Netherlands; Erasmus Medical Center and University, Rotterdam, The Netherlands; Department of Hematology, Hôpital Claude Huriez, Lille, France; Nordic Myeloma Study Group; Italian Multiple Myeloma Network; Turkish Myeloma Study Group; Hemato-Oncologie voor Volwassenen Nederland Intergroupe Francophone du Myélome.